ResearchMoz

United States Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020

GlobalData
Published Date » 2014-05-09
No. Of Pages » 149
   
 "United States Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020", provides key market data on the United States Cardiovascular Monitoring and Diagnostic Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems and Holter Monitoring Systems. 
   
 The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Monitoring and Diagnostic Devices market...

Table of content

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8

2 Introduction 9
2.1 What Is This Report About? 9
2.2 Cardiovascular Monitoring and Diagnostic Devices Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 10

3 Cardiovascular Monitoring and Diagnostic Devices Market, United States 12
3.1 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), 2005-2012 12
3.2 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), 2012-2020 14
3.3 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), 2005-2012 16
3.4 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), 2012-2020 18
3.5 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Average Price ($), 2005-2020 20
3.6 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Distribution Share by Revenue ($m), 2011-2012 22
3.7 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Company Share by Revenue ($m), 2011-2012 23

4 Overview of Key Companies in United States, Cardiovascular Monitoring and Diagnostic Devices Market 25
4.1 GE Healthcare 25
4.1.1 Company Overview 25
4.2 Philips Healthcare 25
4.2.1 Company Overview 25
4.3 CareFusion Corporation 25
4.3.1 Company Overview 25
4.4 Welch Allyn Inc. 26
4.4.1 Company Overview 26
4.5 OSI Systems, Inc. 26
4.5.1 Company Overview 26
4.6 Opto Circuits India Limited 26
4.6.1 Company Overview 26
4.7 Schiller AG 27
4.7.1 Company Overview 27
4.8 Mortara Instrument, Inc. 27
4.8.1 Company Overview 27
4.9 Nihon Kohden Corporation 27
4.9.1 Company Overview 27
4.10 Fukuda Denshi Co., Ltd. 28
4.10.1 Company Overview 28

5 Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products 29

6 Financial Deals Landscape 31
6.1 Acquisition 31
6.1.1 Digirad Acquires Telerhythmics For US$4 Million 31
6.1.2 St. Jude Medical To Acquire CardioMEMS 33
6.2 Asset Transactions 35
6.2.1 BioTelemetry Completes Acquisition Of Cardiac Patient Services Business From Biomedical Systems For US$8.6 Million 35
6.2.2 Mortara Instrument To Acquire Diagnostic Cardiology Product Line Of Cardiac Science For US$21 Million 37
6.3 Debt Offerings 39
6.3.1 Edwards Lifesciences Completes Public Offering Of Notes Due 2018 For US$600 Million 39
6.4 Equity Offerings 41
6.4.1 CardioDx Postpones IPO 41
6.4.2 Bioheart Completes Private Placement Of Shares 43
6.4.3 Bioheart Announces Private Placement Of Shares For US$2 Million 44
6.5 Partnerships 45
6.5.1 Millar Instruments Enters Into Distribution Agreement With CD Leycom 45
6.5.2 Cardionet, Imec, And Delta Enter Into Agreement To Develop Cardiac Monitoring Products 46
6.5.3 Everist Genomics Enters Into Licensing Agreement With Rutgers For Cardiovascular Disease Monitoring Sensor Technology 47
6.5.4 Infraredx Enters Into Co-Development Agreement With Philips 48
6.5.5 Lifewatch Services Enters Into Technology Integration Agreement With Perminova 49
6.5.6 Compumed Entres Into Technology Integration Agreement With GE Healthcare 50
6.6 Private Equity 51
6.6.1 ICU Medical Drops The Sale Of The Company 51
6.6.2 Tenex Capital Acquires Roscoe Medical 53
6.6.3 HealthEdge Investment Fund II Acquires Majority Stake In LifeSync, Maker Of Wireless Electrocardiogram Data Communications System 54
6.7 Venture Financing 55
6.7.1 InfoBionic Raises US$17 Million In First Tranche Of Series B Financing 55
6.7.2 Cardiox Raises US$3.2 Million In Venture Financing 57
6.7.3 Cheetah Medical Raises US$9 Million In Venture Financing 58
6.7.4 Cardiac Insight Raises US$2 Million In Venture Financing 60
6.7.5 Eso-Technologies Raises US$0.6 Million In Series A Financing 61
6.7.6 Nipro Invests US$25 Million In Infraredx 63
6.7.7 Rijuven Raises US$0.3 Million In Venture Financing 65
6.7.8 Cardiac Insight Raises US$1.3 Million In Venture Financing 66
6.7.9 Topera Raises US$25 Million In Series C Financing 67
6.7.10 iRhythm Technologies Raises US$16 Million In Series D Financing 68
6.7.11 Cheetah Medical Raises US$14.4 Million In Extended Series C Financing 70
6.7.12 Endotronix Raises US$1.2 Million In Venture Financing 71
6.7.13 Cardiox Raises US$9.4 Million In Venture Financing 72
6.7.14 Cardiox Raises US$0.4 Million In Venture Financing 73
6.7.15 Angel Medical Systems Raises US$27.5 Million In Initial Closing Of Venture Financing Round 74
6.7.16 iRhythm Technologies Raises US$1.5 Million In Venture Financing 75
6.7.17 iRhythm Technologies Raises US$3.5 Million In Venture Financing 76
6.7.18 Rijuven Raises US$0.5 Million In Venture Financing 78
6.7.19 Aviir Raises US$5 Million In Venture Financing 79
6.7.20 Cardiac Insight Raises US$0.3 Million In Venture Financing 81
6.7.21 Inovise Medical Raises US$0.4 Million In Venture Financing 82
6.7.22 Rijuven Raises US$0.9 Million In Venture Financing 83

7 Recent Developments 84
7.1 Corporate Communications 84
7.1.1 Apr 08, 2014: Ventripoint Corporate Update and Resignation of Director 84
7.1.2 Feb 12, 2014: ICU Medical Names Vivek Jain as New Chief Executive Officer and Chairman 84
7.1.3 Jan 31, 2014: AMAG Pharmaceuticals Announces Issuance of New U.S. Patent for Ferumoxytol 85
7.1.4 Dec 19, 2013: Bioheart Reports Update on CEO 85
7.1.5 Nov 22, 2013: Voyage Care Acquires Ingleby Care 85
7.1.6 Nov 18, 2013: Bioheart's President/CEO Mike Tomas Named Chair of the eMerge Innovate Advisory Board of eMerge Americas 86
7.1.7 Oct 21, 2013: ICU Medical Announces Management Transition 87
7.1.8 Sep 23, 2013: Bioheart Boosts Team with Regulatory, Finance and Administrative Expertise Three New Key Positions Added 88
7.1.9 Sep 19, 2013: Atherotech Diagnostics Lab Bolsters Research Efforts with Addition of Abate as Chief Clinical Officer 88
7.1.10 Sep 13, 2013: Arrhythmia Research Technology Announces Resignation of CFO and Appointment of New Principal Financial Officer 89
7.1.11 Aug 28, 2013: Sheldon T. Anderson Elected to the Board of Directors of Bioheart, Inc. 89
7.1.12 Aug 01, 2013: CardioNet Holding Company Structure Effective 90
7.1.13 Jul 23, 2013: Vincent Caponi Joins Welch Allyn Board of Directors 90
7.1.14 Jun 04, 2013: Cheetah Medical Appoints Chris Hutchison As CEO 91
7.2 Financial Announcements 91
7.2.1 Apr 16, 2014: Osteoarthritis Study shows ActiPatch Therapy Significantly Relieves Knee Pain 91
7.2.2 Mar 27, 2014: Vasomedical Announces Financial Results for Fourth Quarter and Full Year for 2013 93
7.2.3 Feb 12, 2014: ICU Medical Announces Fourth Quarter and Fiscal Year 2013 Results 95
7.2.4 Jan 20, 2014: Pulmonary Embolism Trial Comparing Endovascular Ultrasound to Standard of Care Anticoagulation Published in the American Heart Associations Journal, Circulation 96
7.2.5 Nov 19, 2013: Arrhythmia Research Technology Announces Third Quarter 2013 Results 97
7.2.6 Nov 14, 2013: Vasomedical Recorded 33% Year-over-year Growth in Revenue for the Third Quarter of 2013 98
7.2.7 Nov 05, 2013: Vasomedical to Report Third Quarter 2013 Results on November 14, 2013 99
7.2.8 Nov 05, 2013: BioTelemetry Reports Third Quarter 2013 Financial Results 99
7.2.9 Oct 29, 2013: BioTelemetry to Release Third Quarter 2013 Earnings Results on November 5, 2013 100
7.2.10 Oct 21, 2013: ICU Medical Reports Third Quarter 2013 Results 101
7.2.11 Oct 16, 2013: ICU Medical Announces Time of Third Quarter 2013 Earnings Call 102
7.2.12 Oct 08, 2013: Arrhythmia Research Technology Announces Second Quarter 2013 Results 102
7.2.13 Oct 02, 2013: Arrhythmia Research Technology Announces Updated Preliminary Second Quarter Results 103
7.2.14 Aug 20, 2013: First Databank Acquires Design Clinicals, Medication Reconciliation Solutions Provider 104
7.2.15 Aug 20, 2013: Arrhythmia Research Technology, Inc. Announces Delay in Finalizing Second Quarter Results 106
7.2.16 Aug 13, 2013: Vasomedical Announces Financial Results for the Second Quarter of 2013 106
7.2.17 Aug 06, 2013: Vasomedical to Report Second Quarter 2013 Results on August 13, 2013 107
7.2.18 Jul 30, 2013: CardioNet Reports Second Quarter 2013 Financial Results 108
7.2.19 Jul 23, 2013: CardioNet to Release Second Quarter 2013 Earnings Results on July 30, 2013 109
7.2.20 Jul 18, 2013: ICU Medical Reports Second Quarter 2013 Results 109
7.2.21 Jun 28, 2013: Arrhythmia Research Technology, Inc. Announces First Quarter 2013 Results 110
7.2.22 Jun 17, 2013: Takeda Announces Availability Of Nesina In US Pharmacies 111
7.2.23 Jun 03, 2013: Arrhythmia Reports Revenue Of $20.6m In 2012 112
7.2.24 May 15, 2013: Vasomedical Reports Revenue Of $7.3m In Q1 2013 113
7.2.25 May 09, 2013: Bioheart Reports Q1 2013 Results 114
7.2.26 May 07, 2013: PLC Systems Presents Clinical Data Of RenalGuard System At 60th International Conference Of Israel Heart Society 115
7.3 Government and Public Interest 117
7.3.1 Jan 06, 2014: ICU Medical to Present at the 32nd Annual J.P. Morgan Healthcare Conference 117
7.3.2 Jan 02, 2014: Topera to Present at the 32nd Annual J.P. Morgan Healthcare Conference 117
7.3.3 Dec 31, 2013: Bioheart to Present at Vail Symposium's Winter Program on Cell Therapy 117
7.3.4 Dec 02, 2013: ZOLL Summit 2014 Call for Presentations 117
7.3.5 Nov 25, 2013: Topera to Present at the 25th Annual Piper Jaffray Health Conference 118
7.3.6 Nov 21, 2013: ICU Medical to Present at the Piper Jaffray 25th Annual Healthcare Conference 118
7.3.7 Oct 23, 2013: Additional dedicated trainer hospital established in the USA 118
7.3.8 Aug 09, 2013: IMRIS CEO Jay D. Miller to present at Canaccord Genuity 33rd Annual Global Growth Conference 118
7.4 Legal And Regulatory 119
7.4.1 Apr 17, 2014: Boston Heart Granted New York Laboratory Permit for Diagnostic Testing 119
7.5 Other Significant Developments 119
7.5.1 Feb 24, 2014: AliveCor Offers Integration With Practice Fusion's Electronic Health Records Platform 119
7.5.2 Feb 20, 2014: Boston Heart Diagnostics Awarded $1.0 Million in Tax Incentives from the Massachusetts Life Sciences Center 120
7.5.3 Dec 04, 2013: BioTelemetry, Inc. Announces Reduction to Medicare Reimbursement for Remote Cardiac Monitoring Services 121
7.5.4 Dec 02, 2013: Bioheart Announces Agreement With StemMD to Provide Bioheart Therapies to Its Network 121
7.5.5 Nov 18, 2013: AliveCor transforms Heart Monitor into eHealth Service 121
7.5.6 Nov 15, 2013: Millar Appointed Exclusive US Distributor of CD Leycom INCA Pressure-Volume Loop System 122
7.5.7 Oct 25, 2013: Bioheart Announces Agreement With Anosis to Distribute Products in the Middle East 123
7.5.8 Oct 16, 2013: Bioheart Announces Contract With African-Middle East Medical to Begin Distributing Stem Cell Products in Uganda 123
7.5.9 Oct 09, 2013: $2 Million Awarded to Sutter Health, IBM and Geisinger Health System to Study Heart Failure Prediction 123
7.5.10 Aug 23, 2013: Arrhythmia Research Technology Receives NYSE MKT LLC Exchange Compliance Notice 125
7.5.11 Jul 09, 2013: Behrman Capital Portfolio Company Atherotech Completes Recapitalization 125
7.6 Product News 125
7.6.1 Apr 16, 2014: AtCor Medical Receives Patent in USA 125
7.6.2 Mar 27, 2014: First Patients Enrolled in Medtronic Clinical Study Designed to Identify Patients at High Risk for Sudden Cardiac Arrest in Developing Countries 126
7.6.3 Mar 17, 2014: Vasomedical Announces Biox's MobiCare Wireless Patient Monitors Receives Marketing Approval in China 127
7.6.4 Feb 13, 2014: New Data Support Use of iRhythm's ZIO Service to Identify Cardiac Arrhythmias in Stroke and TIA Patients 127
7.6.5 Jan 22, 2014: UCLA researchers develop risk calculator to predict survival in heart failure patients 128
7.6.6 Jan 06, 2014: FDA Reclassifies ECP Devices for Refractory Angina as Class II 130
7.6.7 Jan 02, 2014: ZIO Service Identifies Significantly More Cardiac Arrhythmias Than the Traditional Holter Monitor, According to Study Published Online in the American Journal of Medicine 130
7.6.8 Nov 25, 2013: Independent Multi-Center Clinical Study Shows the Use of Toperas 3D Mapping System Improved Long-Term Outcomes for Atrial Fibrillation Patients 131
7.6.9 Nov 18, 2013: AliveCor Transforms Heart Monitor into eHealth Service 132
7.6.10 Oct 07, 2013: MDxHealths Prostate Cancer Test Meets Endpoints In DOCUMENT Trial 133
7.6.11 Aug 23, 2013: AliveCor Launches New Feature to Enhance Visual Quality of ECG 135
7.6.12 May 14, 2013: iCardiac Releases StudyView Module for iClinica 4G Cardiac Safety Software Platform 135
7.7 Research And Development 136
7.7.1 Jun 04, 2013: Immunicum's Intuvax Is Registered As Brand In EU At Office for Harmonization in the Internal Market 136
7.8 Strategy And Business Planning 136
7.8.1 Nov 25, 2013: Bioheart Announces New Clinical Site in Mexico 136
7.8.2 Nov 06, 2013: Welch Allyn Establishes New Regional Headquarters, Operations Center in The Netherlands 137
7.8.3 Nov 04, 2013: Bioheart Announces Agreement With Global Stem Cell Group to Provide Bioheart Therapies and Training 138
7.8.4 Jul 25, 2013: First Injection of Dotarem in US Performed at Cincinnati Children's Hospital Medical Center 138
7.8.5 Jul 02, 2013: Apogenix Strengthens Patent Position for Apocept In Europe And Canada 139

8 Appendix 141
8.1 Research Methodology 142
8.1.1 Coverage 142
8.1.2 Secondary Research 142
8.1.3 Primary Research 143
8.1.4 Market Modeling and Forecasting 144
8.1.5 Company Share Analysis 147
8.1.6 Distribution Share Analysis 148
8.2 Expert Panel 148
8.3 GlobalData Consulting 149
8.4 Contact Us 149
8.5 Disclaimer 149

List of Tables


Table 1: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 13
Table 2: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 15
Table 3: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), Historic, 2005-2012 17
Table 4: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), Forecast, 2012-2020 19
Table 5: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Average Price ($), Historic, 2005-2012 20
Table 6: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Average Price ($), Forecast, 2012-2020 21
Table 7: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 22
Table 8: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 24
Table 9: Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products 29
Table 10: Digirad Acquires Telerhythmics For US$4 Million 31
Table 11: St. Jude Medical To Acquire CardioMEMS 33
Table 12: BioTelemetry Completes Acquisition Of Cardiac Patient Services Business From Biomedical Systems For US$8.6 Million 35
Table 13: Mortara Instrument To Acquire Diagnostic Cardiology Product Line Of Cardiac Science For US$21 Million 37
Table 14: Edwards Lifesciences Completes Public Offering Of Notes Due 2018 For US$600 Million 39
Table 15: CardioDx Postpones IPO 41
Table 16: Bioheart Completes Private Placement Of Shares 43
Table 17: Bioheart Announces Private Placement Of Shares For US$2 Million 44
Table 18: Millar Instruments Enters Into Distribution Agreement With CD Leycom 45
Table 19: Cardionet, Imec, And Delta Enter Into Agreement To Develop Cardiac Monitoring Products 46
Table 20: Everist Genomics Enters Into Licensing Agreement With Rutgers For Cardiovascular Disease Monitoring Sensor Technology 47
Table 21: Infraredx Enters Into Co-Development Agreement With Philips 48
Table 22: Lifewatch Services Enters Into Technology Integration Agreement With Perminova 49
Table 23: Compumed Entres Into Technology Integration Agreement With GE Healthcare 50
Table 24: ICU Medical Drops The Sale Of The Company 51
Table 25: Tenex Capital Acquires Roscoe Medical 53
Table 26: HealthEdge Investment Fund II Acquires Majority Stake In LifeSync, Maker Of Wireless Electrocardiogram Data Communications System 54
Table 27: InfoBionic Raises US$17 Million In First Tranche Of Series B Financing 55
Table 28: Cardiox Raises US$3.2 Million In Venture Financing 57
Table 29: Cheetah Medical Raises US$9 Million In Venture Financing 58
Table 30: Cardiac Insight Raises US$2 Million In Venture Financing 60
Table 31: Eso-Technologies Raises US$0.6 Million In Series A Financing 61
Table 32: Nipro Invests US$25 Million In Infraredx 63
Table 33: Rijuven Raises US$0.3 Million In Venture Financing 65
Table 34: Cardiac Insight Raises US$1.3 Million In Venture Financing 66
Table 35: Topera Raises US$25 Million In Series C Financing 67
Table 36: iRhythm Technologies Raises US$16 Million In Series D Financing 68
Table 37: Cheetah Medical Raises US$14.4 Million In Extended Series C Financing 70
Table 38: Endotronix Raises US$1.2 Million In Venture Financing 71
Table 39: Cardiox Raises US$9.4 Million In Venture Financing 72
Table 40: Cardiox Raises US$0.4 Million In Venture Financing 73
Table 41: Angel Medical Systems Raises US$27.5 Million In Initial Closing Of Venture Financing Round 74
Table 42: iRhythm Technologies Raises US$1.5 Million In Venture Financing 75
Table 43: iRhythm Technologies Raises US$3.5 Million In Venture Financing 76
Table 44: Rijuven Raises US$0.5 Million In Venture Financing 78
Table 45: Aviir Raises US$5 Million In Venture Financing 79
Table 46: Cardiac Insight Raises US$0.3 Million In Venture Financing 81
Table 47: Inovise Medical Raises US$0.4 Million In Venture Financing 82
Table 48: Rijuven Raises US$0.9 Million In Venture Financing 83
Table 49: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 144

List of Figures


Figure 1: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 12
Figure 2: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 14
Figure 3: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), Historic, 2005-2012 16
Figure 4: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), Forecast, 2012-2020 18
Figure 5: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Company Share (%), 2012 23
Figure 6: GlobalData Epidemiology-Based Forecasting Model 146
Figure 7: GlobalData Capital Equipment-Based Forecasting Model 147
Figure 8: Primary Interviews by Participant Type (%) 148

Upcoming Reports:

Medical Nonwoven Disposables Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Medical nonwoven disposables are important products in the global healthcare industry as they provide hygiene benefits over the woven fabrics. Woven fabrics used in hospitals, clinics and physician offices are vulnerable to hospital acquired infections (HAIs) and other infections such as AIDs and hepatitis. Medical nonwoven disposables prevent transmission of these infections to some extent since they are soon disposed of. Therefore, the increasing awareness about these infections and efforts to control these infections are driving the global market for medical nonwoven disposables...
Desalter Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth And Forecast, 2013 - 2019
By - Transparency Market Research
Desalter is a part of processing unit in an oil refinery. It is the first unit where raw crude is processed before processing it into crude distillation unit. Salts in crude are generally contained in residual water suspended in oil phase. Desalter is used to remove salt, water, sediment and suspended solids. These impurities are removed from the crude in order to prevent corrosion to other units, to avoid fouling and coking, to avoid high energy consumption effected by sediments and suspended solid, to avoid catalyst poisoning, etc. a desalting system consist of a mixing device and an...
Alternative Fuels Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Worldwide increasing prices of crude oil and growing demand for fuel operated machinery is encouraging the need for alternative fuels. Currently, natural gas, ethanol, methanol, biodiesel, propane and others are some of the best alternatives available. With the advent of new technology, these fuels are used in number of vehicle applications. Use of these alternative fuels in vehicles can reduce emission of harmful pollutants.   Alternative fuels market has not only revolutionized transportation industry, but it has also created new boundary for expansion of emerging energy...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Export market in New Zealand driven by innovative and high-value food products
Jul 29, 2014  
Demand for beverages and high value foods in Asia are driving the food and beverage industry in New Zealand. Also there is high demand for dairy products, seafood, meat and processed foods in the Asian economies which fuel the give an export boost to the economy of New Zealand.  Asia has a rapidly growing market for food which in turn is highly beneficial for New Zealand’s export...
Sony plans revival of PlayStation with network services
Jul 29, 2014  
After a nearly USD 10 billion loss over the last six years, Sony Corp has plans of reviving its consumer electronics hero – the PlayStation. Sony will be repositioning the video game console as a center of streamed network services such as social media, music and movies apart from games. The matter is still in its infancy stage of discussion and the plan is to generate revenue from the...
OnePlus One ready to launch it smart phone in India
Jul 28, 2014  
Chinese smart phones are gaining popularity in the Indian market. OnePlus, a Chinese smart phones company, is ready to launch the invitation-only One smart phone in India.  Many Chinese smart phone brands have got inspired by the success of another smart phone brand called Xiaomi which had successfully launched the Mi 3, a smart phone in the Indian market. The OnePlus One is a typical...
Danone all set to sell its business to Hospira
Jul 28, 2014  
According to the Financial Times, Danone, a French dairy group is aiming at selling its business pertaining to medical nutrition to Hospira, a US group. The deal value is estimated at $ 5 billion.  The plan is still in the pipeline as nothing with respect to the business is fully confirmed or certain. Representatives of neither business groups were willing to comment on the same. ...
At a USD 62 Price Tag, the Karbonn A50S Smartphone Could Challenge Likes of Apple and Samsung in India
Jul 28, 2014  
A USD 62 smartphone launched in the Indian market by Karbonn could signal stiff competition for behemoths such as Apple that makes the iPhone and Samsung, known best for its Galaxy smartphone range. The Karbonn A50S, which has been officially launched in India, can also be ordered by customers outside of the country via online stores, and delivered to their doorstep. Given its exceptionally...